Ajayi Samuel, Kehinde Folasade, Cooperberg David, Touch Suzanne M
Division of Neonatology, Hendrick Medical Center, Abilene, Tex.
Division of Neonatology, St. Christopher's Hospital for Children, Philadelphia, Pa.
Pediatr Qual Saf. 2021 May 5;6(3):e407. doi: 10.1097/pq9.0000000000000407. eCollection 2021 May-Jun.
Time of medication delivery from the onset of illness is one factor that determines disease outcomes. In this study, we aimed to reduce the average time from admission to the first dose of antibiotic by at least 30% and increase the percentage of neonates receiving the first antibiotic dose within 1 hour of neonatal intensive care unit arrival to 50% over 12 months in asymptomatic neonates 34 weeks and older estimated gestational age with exposure to maternal chorioamnionitis as a sample population.
This study involved 135 infants 34 weeks and older gestational age exposed to chorioamnionitis. We documented the demographic characteristics of mothers and infants. We monitored time to the administration of the first dose of antibiotics through multiple plan-do-study-act cycles. We identified barriers to timely antibiotic administration and targeted them with multipronged interventions in plan-do-study-act cycles. Process measures were displayed monthly using X-bar/S control charts and P charts. We applied established rules for detecting a special cause.
We reduced the meantime to the first dose of antibiotics from 130 to 78 minutes (40% reduction). The percentage of infants who received the first antibiotic dose within 60 minutes rose from 5.8% to 36.3% during the study period. Special cause improvement was seen in all process measures. The most significant improvement seen was in the time to obtain a blood culture and the interval between intravenous access placement and antibiotic delivery.
Multipronged interventions can help improve timely medication delivery to neonates in the neonatal intensive care unit in this example of infants exposed to chorioamnionitis.
从发病开始给药的时间是决定疾病转归的一个因素。在本研究中,我们旨在将从入院到首次给予抗生素的平均时间至少缩短30%,并在12个月内将无症状且估计胎龄34周及以上、母亲患有绒毛膜羊膜炎的新生儿在进入新生儿重症监护病房后1小时内接受首剂抗生素的比例提高到50%,以此作为样本群体。
本研究纳入了135例胎龄34周及以上、母亲患有绒毛膜羊膜炎的婴儿。我们记录了母亲和婴儿的人口统计学特征。我们通过多个计划-执行-研究-行动循环来监测首次给予抗生素的时间。我们确定了及时给予抗生素的障碍,并在计划-执行-研究-行动循环中通过多方面干预来解决这些障碍。每月使用X-bar/S控制图和P图展示过程指标。我们应用既定规则来检测特殊原因。
我们将首次给予抗生素的平均时间从130分钟缩短至78分钟(缩短了40%)。在研究期间,在60分钟内接受首剂抗生素的婴儿比例从5.8%升至36.3%。在所有过程指标中均观察到特殊原因导致的改善。改善最为显著的是获取血培养的时间以及静脉置管与给予抗生素之间的间隔时间。
在这个母亲患有绒毛膜羊膜炎的婴儿的例子中,多方面干预有助于改善新生儿重症监护病房中新生儿的及时给药情况。